Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Protein interaction causing rare but deadly vaccine-related clotting found Discovery means potential protective treatments could be developed to block thrombosis from developing following vaccination.
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
21 November 2023 Gender prize gap in science exists as one in eight female academics win awards named after men Males win 88% of awards named after men, and 53% of prizes named after women
30 October 2023 Protein interaction causing rare but deadly vaccine-related clotting found Discovery means potential protective treatments could be developed to block thrombosis from developing following vaccination.
19 October 2023 Senior leader receives Vitae ICE Award for work around menopause awareness. Helen Matthews, Head of Operations at the Institute of Clinical Sciences, University of Birmingham, has been awarded the Vitae ICE Award for work on menopause.
12 October 2023 Birmingham Platelet Group delivers breakthrough ‘nanobody’ technology Birmingham researchers created antibody fragments called nanobodies to help scientists understand more about platelet disorders such as bleeding or thrombosis
27 September 2023 Patients with Atrial High-Rate Episodes should not be treated with anticoagulant, trial finds The NOAH-AFNET 6 trial shows that giving a direct oral anticoagulant to patients with these device-detected arrhythmias has no benefits and increases risks.
14 September 2023 New grant award to find better treatments for thrombo-inflammatory diseases Birmingham researchers will target Galectin-9, a protein involved in thrombo-inflammation processes.
15 August 2023 Novel biologic Ab-IPL-IL-17™ shows promise for rheumatoid arthritis and inflammatory bowel disease The antibody targets a section of signalling proteins that play a central role in sustaining inflammation during onset and progression of autoimmune diseases